Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala

J Psychopharmacol. 2013 Oct;27(10):903-14. doi: 10.1177/0269881113494106. Epub 2013 Jul 2.

Abstract

Background: The serotonin 2A (5-HT2A) receptor has been implicated in neural-processing of emotionally salient information. To elucidate its role in processing of fear and anger, healthy individuals were studied with functional magnetic resonance imaging (fMRI) after 5-HT2A receptor blockade, while judging the gender of neutral, fearful and angry faces.

Methods: 5-HT2A receptors were blocked with ketanserin to a variable degree across subjects by adjusting the time between ketanserin-infusion and onset of the fMRI protocol. Neocortical 5-HT2A receptor binding in terms of the binding potential (BPp ) was assessed prior to fMRI with (18)F-altanserin positron emission tomography (PET) and subsequently integrated in the fMRI data analysis. Also functional connectivity analysis was employed to evaluate the effect of ketanserin blocking on connectivity.

Results: Compared to a control session, 5-HT2A receptor blockade reduced the neural response to fearful faces in the medial orbitofrontal cortex (OFC), independently of 5-HT2A receptor occupancy or neocortical 5-HT2A receptor BPp . The medial OFC also showed increased functional coupling with the left amygdala during processing of fearful faces depending on the amount of blocked 5-HT2A receptors.

Conclusions: 5-HT2A receptor mediated signaling increases the sensitivity of the OFC to fearful facial expressions and regulates the strength of a negative feedback signal from the OFC to amygdala during processing of fearful faces.

Keywords: Functional magnetic resonance imaging; emotion; fearful faces; ketanserin; positron emission tomography; serotonin; serotonin 2A receptors.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amygdala / drug effects*
  • Amygdala / metabolism
  • Amygdala / physiology
  • Anger
  • Citalopram / pharmacology
  • Facial Expression*
  • Fear*
  • Female
  • Frontal Lobe / drug effects*
  • Frontal Lobe / metabolism
  • Frontal Lobe / physiology
  • Functional Neuroimaging
  • Healthy Volunteers
  • Humans
  • Ketanserin / pharmacology
  • Magnetic Resonance Imaging
  • Male
  • Neural Pathways / drug effects
  • Neural Pathways / physiology
  • Photic Stimulation
  • Radioligand Assay
  • Reaction Time / drug effects
  • Receptor, Serotonin, 5-HT2A / metabolism*
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Serotonin 5-HT2 Receptor Antagonists / pharmacology*
  • Sex Factors
  • Tryptophan / metabolism
  • Visual Perception / drug effects*
  • Visual Perception / physiology

Substances

  • Receptor, Serotonin, 5-HT2A
  • Serotonin 5-HT2 Receptor Antagonists
  • Serotonin Uptake Inhibitors
  • Citalopram
  • Tryptophan
  • Ketanserin